Skip to main content
OpenTrials
Completed

NCT Number: NCT01650987

Toxicities of Cervix and Corpus Uteri Carcinomas Treatment and Evaluation of Impact on Sexual Function

Evaluate the toxicities of cervix and corpus uteri carcinomas treatment

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Corpus Uteri Carcinoma Carcinoma Neoplasms Neoplasms by Histologic Type Neoplasms, Glandular and Epithelial

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Primary location

Centre Oscar Lambret

Lille, 59020, France

About this study

Evaluate the toxicities of cervix and corpus uteri carcinomas treatment on sexual function after treatment (radiotherapy and/or surgery)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

  • Inclusion Criteria:
  • Patients whose treatment is provided to Centre Oscar Lambret
  • With a corpus uteri adenocarcinoma, no metastatic, treated by:
  • Surgery and observation without complementary treatment
  • Or surgery and adjuvant radiotherapy
  • Or Surgery and curietherapy of vaginal dome
  • With a cervix carcinoma, stade IA2 to IIB proximal, treated by :
  • External radiochemotherapy and curietherapy
  • Or only surgery
  • Or pre-surgical curietherapy and surgery
  • Age > 18 years

Treatment and study plan

Primary outcomes

  1. Toxicities including on sexual function

    Time frame: up to 3 years

    According to Lent-Soma, NCICTC-AE v3.0, Franco-Italian Glossary

Secondary outcomes

  1. Compare the various scales of toxicity

    Time frame: up to 3 years

    Compare the various scales of toxicity

  2. Study the sexual behavior modifications

    Time frame: up to 3 years

    According to a questionnaire and a personal discussion

  3. Specify correlation modifications of sexual behavior

    Time frame: up to 3 years

    Specify the existence of a correlation between toxicities included modifications and sexual behavior modifications

Sponsors and collaborators

Lead sponsor

Centre Oscar Lambret

Other

Registry information

Official study title

Prospective Observational Study of Toxicities of Cervix and Corpus Uteri Carcinomas Treatment and Evaluation of Impact on Sexual Function

Acronym: SEXUTOX

Important dates

Study start
2009
Primary completion
2015
Study completion
2015
First posted
Jul 26, 2012
Registry last updated
Aug 8, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.